Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
about
A pilot proteomic study of amyloid precursor interactors in Alzheimer's diseaseThe toxicity of amyloid β oligomersOxidative stress and covalent modification of protein with bioactive aldehydesInvolvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's diseaseThe proteome of neural stem cells from adult rat hippocampusUbiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunctionIt Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer DiseaseApproaches for targeted proteomics and its potential applications in neuroscienceThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionViruses and neurodegenerationThe roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic reviewAge effect on myocellular remodeling: response to exercise and nutrition in humansOxidative stress in aging: advances in proteomic approachesAbeta, oxidative stress in Alzheimer disease: evidence based on proteomics studiesMultiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological ImplicationsInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingProteomics of protein post-translational modifications implicated in neurodegenerationDifferential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residuesThe ubiquitin-proteasome system in Alzheimer's diseaseMutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implicationChronic ethanol feeding affects proteasome-interacting proteinsRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Redox Proteomics: A Key Tool for New Insights into Protein Modification with Relevance to DiseaseRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseasesProteomic analysis for protein carbonyl as an indicator of oxidative damage in senescence-accelerated mice.Differential expression of mitochondrial and extramitochondrial proteins in lymphocytes of male broilers with low and high feed efficiency.A density-based proteomics sample fractionation technology: folate deficiency induced oxidative stress response in liver and brain.Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's diseaseOxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Mass spectrometry assessment of ubiquitin carboxyl-terminal hydrolase L1 partitioning between soluble and particulate brain homogenate fractionsGlutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Protein carbonylation.Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junctionUbiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.Role of oxidative carbonylation in protein quality control and senescence.
P2860
Q24310599-9E26C6E9-04D1-4CA9-9740-33F8FE32A228Q24631757-49E3E614-AF87-4D36-8D5D-572CADA80993Q24649676-1BD799FE-19A3-4245-AF55-BF81FEB8F00AQ24684559-A6783DC1-9472-49D2-97C1-457AF0100E5BQ24805131-D5A4759F-ACC9-4219-86ED-27C4F55D2763Q26741828-DD5EBE94-AF1B-4B28-95CE-076CF576BF35Q26765816-8507DF89-EA8C-4AB8-ADC7-F7748001A4ABQ26786427-33E2BBCE-82C6-4D5D-8FB8-19F02A3D69F3Q26823454-E78E5E6D-E060-41CE-A49D-2AD06E6224EFQ26827320-D1ED4721-118A-4EF2-A9E8-406DCE87B081Q26865358-F28E6E82-EA26-4CD0-A45E-1FD4877B303DQ26991740-1BDE1D76-B614-4CB5-847E-31730F780FBDQ27008396-F605F507-9C8B-4B6D-9AC9-3FF594A92A7BQ27024546-E04885EC-0984-425C-B897-17455E52C32CQ27025199-CF915B7E-F76A-4802-A7CF-92B882C69E43Q27693922-94C6AC2F-88E1-43ED-8D01-4E0A8C0712CAQ28074448-2553B8E8-EE4B-4876-B2D9-0E7298561C52Q28076999-6A45BF4A-F52C-41E3-A47F-57F19E68ED2EQ28088631-247C33EB-7A4C-4D5C-947B-36E37A79A769Q28211108-CA634121-6959-44A3-B308-C660FC3C7EE5Q28268311-AC2A5F9E-8FE2-46A8-AAFB-2E0568ABBBC0Q28510031-BB57AE04-21B8-4C2C-B9B3-F633ACC27750Q28582843-B0795B59-D1ED-4698-9128-D34BA73A7B2AQ30367032-97B87958-39AF-4984-8AB6-FD52215851FAQ30394816-A795777B-E444-4671-9ECE-7FC3490D73CFQ30395140-00544530-24A4-469D-BB59-5C0E1FD9BA15Q30446460-DF42305E-1981-43ED-BCAC-A32A021A979CQ33235503-DCC20C1C-F3A7-4EE1-8113-FE2C5F34E074Q33260812-DE9828AF-79D4-4032-859E-50373D6B956AQ33265042-EAF084A6-EF33-4781-89AF-731A458BBE7CQ33301619-778E85EB-7A7E-4C3C-A5F7-6F53C59C5506Q33494148-69AF170F-B10C-4B19-ABFF-684568E04966Q33506441-26854003-6C12-40C6-839F-39A203BDE23BQ33580301-907B66B7-9442-4147-8722-D9BA30AA8C43Q33607471-2D60DF3B-8240-4EE6-AA9D-9F84325E6F96Q33639885-6DCB6515-8CD2-4245-A507-4E5B6D5FF07BQ33649892-9C2822F5-1109-482C-A2DA-AD71E1309668Q33667738-38764179-F439-4D43-962E-439C428A2293Q33764254-BA295E4C-DD4F-4494-891E-9A3987454B7FQ33841697-7929E60F-C1A1-46E8-84B3-9A7157395418
P2860
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Proteomic identification of ox ...... arboxy-terminal hydrolase L-1.
@ast
Proteomic identification of ox ...... arboxy-terminal hydrolase L-1.
@en
type
label
Proteomic identification of ox ...... arboxy-terminal hydrolase L-1.
@ast
Proteomic identification of ox ...... arboxy-terminal hydrolase L-1.
@en
prefLabel
Proteomic identification of ox ...... arboxy-terminal hydrolase L-1.
@ast
Proteomic identification of ox ...... arboxy-terminal hydrolase L-1.
@en
P2093
P1476
Proteomic identification of ox ...... arboxy-terminal hydrolase L-1.
@en
P2093
Alessandra Castegna
Jon B Klein
Marina Aksenova
Michael Aksenov
Rosemarie Booze
William M Pierce
William R Markesbery
P304
P356
10.1016/S0891-5849(02)00914-0
P577
2002-08-01T00:00:00Z